Polypharmacology of Gongronema latifolium leaf secondary metabolites against protein kinases implicated in Parkinson's disease and Alzheimer's disease-Reference-Cited by-同舟云学术

Polypharmacology of Gongronema latifolium leaf secondary metabolites against protein kinases implicated in Parkinson's disease and Alzheimer's disease

Published:2021-07 Issue: Volume:12 Page:e00826
ISSN:2468-2276
Container-title:Scientific African
language:en
Short-container-title:Scientific African

Author:

Oyinloye Babatunji Emmanuel,Iwaloye Opeyemi,Ajiboye Basiru Olaitan

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference42 articles.

1. Metals and neurodegenerative diseases. A systematic review;Cicero;Environ. Res.,2017

2. Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine;Kovacs;Int. J. Mol. Sci.,2016

3. Neuropathologic changes in Alzheimer's disease;Wenk;J. Clin. Psychiatry,2003

4. Neuropathology of Alzheimer's disease;Perl;Mt. Sinai J. Med.,2010

5. Alzheimer's disease facts and figures;Maslow;Alzheimer's Dement,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholinergic Inhibition and Antioxidant Potential of Gongronema latifolium Benth Leaf in Neurodegeneration: Experimental and In Silico Study;Cell Biochemistry and Biophysics;2024-08-09

2. Enzymatic Metabolic Switches of Astrocyte Response to Lipotoxicity as Potential Therapeutic Targets for Nervous System Diseases;Pharmaceuticals;2024-05-16

3. Spondias mombin flavonoids showed super-binder ability with downstream molecular targets of Parkinson's disease: A structural study;Informatics in Medicine Unlocked;2024

4. Spondias mombin flavonoids showed super-binder ability with Downstream Molecular Targets of Parkinson’s Disease: Folkloric-therapy assessment as a Scaffold for Structural Studies in Neurodegenerative disease;2023-12-29

5. Probing the multitargeting potential of n-hexane fraction of Gongronema latifolium leaves in neurodegeneration via in vitro, GC–MS and in silico studies;Future Journal of Pharmaceutical Sciences;2023-10-09